Article Details

FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer

Retrieved on: 2023-10-12 17:07:50

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer. View article details on HISWAI: https://www.pharmacytimes.com/view/fda-approves-encorafenib-plus-binimetinib-combination-for-non-small-cell-lung-cancer

Excerpt

Encorafenib (Braftovi; Pfizer Inc) and binimetinib (Mektovi; Pfizer Inc) approved for the treatment of patients with metastatic non-small cell ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up